Target intelligence / Profile preview

Free iron ion

Molecular classification
Other (inorganic ion), Metal ion (iron)
01

Overview

Free iron ions refer to iron atoms present in biological systems in their ionic forms (most commonly ferrous, Fe²⁺, and ferric, Fe³⁺) that are not tightly bound to proteins or cofactors. While transition metal ions such as iron are essential for life, especially as enzymatic cofactors and in oxygen transport, unshielded iron ions can catalyze the production of reactive oxygen species, leading to oxidative stress, cell damage, and disease. Iron is tightly regulated in cells to minimize the amount of labile or free iron, and excess free iron is stored in ferritin or bound by transferrin to prevent toxicity. Therapeutic interventions aim to reduce free iron using chelators in cases of iron overload. “Free iron ions” is not a defined molecular structure or a protein target but a chemical species whose quantity and reactivity are central to health, disease, and treatment strategies related to iron homeostasis.

Other names
Labile ironunbound ironfree Fe²⁺free Fe³⁺non–protein-bound iron
02

Mechanism of action

Chelation of free iron ions (drugs bind iron and promote its excretion or sequestration, reducing toxicity and oxidative damage)

03

Biological functions

Oxygen transport (via iron in hemoglobin and myoglobin, though not as free ions)Cellular respiration (as a redox catalyst in the electron transport chain, though as part of cofactors)DNA synthesis and repairEpigenetic regulationRedox reactions/oxidative metabolismGeneration of reactive oxygen species (when uncontrolled)
04

Disease associations

Iron overload disorders (e.g., hemochromatosis)Neurodegenerative diseasesCancer (due to role in proliferation and DNA synthesis, and iron-induced oxidative stress)Inflammation (iron sequestration and immune cell regulation)Infection (iron metabolism is tightly regulated to restrict pathogen access)Cardiovascular disease (due to iron-induced oxidative damage)
05

Safety considerations

Iron-mediated oxidative stress (free iron catalyzes formation of ROS via Fenton reaction, damaging DNA, proteins, and lipids)Iron overload toxicity (particularly with transfusions or hereditary disease)Potential for promoting infection (organisms utilize free iron for growth)
06

Interacting drugs

Iron chelators (e.g., deferoxamine, deferiprone, deferasirox)
07

Biomarkers

Serum ferritin (reflects storage, not free iron)Transferrin saturation (indicates overall iron status, not specifically free ions)Labile plasma iron (LPI), Non–transferrin-bound iron (NTBI) as specific measures for labile/free iron

Beyond the preview

Go deeper on Free iron ion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Free iron ion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call